SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alteon (ALT)
ALT 5.660+2.9%Jan 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. T. who wrote (166)12/4/1997 1:12:00 PM
From: Mac S. Giballa  Read Replies (1) of 318
 
1998 will close out the big studies- ACTION I and ESRD. All indications look good. Remember this drug is potentially huge, in animal studies it can keep diabetics from developin most complications such as kidney disease and blindness. Every diabetic in the world could eventually end up on it, which would make the largest selling drug in history by far. Of course this is an absolutely best case scenario, but given the potential- at $20 a share the market cap is still only $300 million. Centocor has a cap of $3 billion with a drug that sells only $240 million.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News